---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008387"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2025-02-26T23:59:59+00:00"
generated_at: "2026-05-26T03:13:15.179292+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma induces exercise of 302K warrants at $2.27, raises ~$0.7M; issues new warrants for 604K shares

## Summary
- Entered inducement letters with holders of 302,069 existing warrants to exercise at reduced price of $2.27/share, raising ~$0.7M gross proceeds.
- In exchange, issued Series A (5-year term) and Series B (18-month term) inducement warrants at $2.02 exercise price for up to 604,138 shares total.
- New warrants are unregistered; company to file resale registration statement within 30 days.
- Net proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001493152-25-008387
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2025-02-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000149315225008387/0001493152-25-008387-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000149315225008387/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008387
- JSON: https://secwatch.observer/filing/0001493152-25-008387.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008387.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.